• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Different effects of atenolol and nebivolol on coronary flow reserve.

作者信息

Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim I, Sezgin A T, Muderrisoglu H

出版信息

Heart. 2006 Nov;92(11):1690-1. doi: 10.1136/hrt.2005.084079.

DOI:10.1136/hrt.2005.084079
PMID:17041122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1861249/
Abstract
摘要

相似文献

1
Different effects of atenolol and nebivolol on coronary flow reserve.阿替洛尔和奈必洛尔对冠脉血流储备的不同影响。
Heart. 2006 Nov;92(11):1690-1. doi: 10.1136/hrt.2005.084079.
2
Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.奈必洛尔和阿替洛尔对原发性高血压患者二尖瓣舒张期充盈参数的不同影响。
Adv Ther. 2008 Jun;25(6):619-26. doi: 10.1007/s12325-008-0065-3.
3
Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.奈必洛尔与阿替洛尔对原发性高血压的降压及β1-肾上腺素能受体拮抗作用比较
Clin Exp Hypertens. 1993 May;15(3):501-9. doi: 10.3109/10641969309041625.
4
Nebivolol: a new beta blocker on the horizon.奈必洛尔：即将问世的新型β受体阻滞剂。
Indian Heart J. 2000 Jan-Feb;52(1):86-8.
5
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.β受体阻滞剂治疗舒张性心力衰竭和动脉高血压患者。阿替洛尔与奈必洛尔长期疗效的前瞻性、随机对照研究。
Eur J Heart Fail. 2003 Oct;5(5):621-7. doi: 10.1016/s1388-9842(03)00054-0.
6
Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.奈必洛尔和阿替洛尔对高血压患者中心动脉压的影响：一项多中心、随机、双盲研究。
Blood Press. 2014 Jun;23(3):181-8. doi: 10.3109/08037051.2013.840421. Epub 2013 Sep 23.
7
Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.奈必洛尔和阿替洛尔对高血压患者胰岛素敏感性及血流动力学的影响。
J Hypertens. 2001 Aug;19(8):1429-35. doi: 10.1097/00004872-200108000-00011.
8
Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.奈必洛尔治疗高血压：一项评估其降压疗效及对生活质量影响的双盲安慰剂对照多中心研究。
J Cardiovasc Pharmacol. 1993 Jun;21(6):856-62.
9
The role of the new beta-blockers in treating cardiovascular disease.新型β受体阻滞剂在治疗心血管疾病中的作用。
Am J Hypertens. 2005 Dec;18(12 Pt 2):169S-176S. doi: 10.1016/j.amjhyper.2005.09.009.
10
Nebivolol: a third-generation beta-blocker for hypertension.奈必洛尔：一种用于治疗高血压的第三代β受体阻滞剂。
Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007.

引用本文的文献

1
Current Evidence-Based Treatment of Angina With Nonobstructive Coronary Arteries (ANOCA).非阻塞性冠状动脉性心绞痛（ANOCA）的当前循证治疗
J Soc Cardiovasc Angiogr Interv. 2025 Apr 15;4(7):102633. doi: 10.1016/j.jscai.2025.102633. eCollection 2025 Jul.
2
Effect of Beta Blockers on the Hemodynamics and Thrombotic Risk of Coronary Artery Aneurysms in Kawasaki Disease.β受体阻滞剂对川崎病冠状动脉瘤血流动力学及血栓形成风险的影响
J Cardiovasc Transl Res. 2023 Aug;16(4):852-861. doi: 10.1007/s12265-023-10370-0. Epub 2023 Mar 17.
3
Effects of Oral Drugs on Coronary Microvascular Function in Patients Without Significant Stenosis of Epicardial Coronary Arteries: A Systematic Review and Meta-Analysis of Coronary Flow Reserve.口服药物对无显著心外膜冠状动脉狭窄患者冠状动脉微血管功能的影响：冠状动脉血流储备的系统评价和荟萃分析
Front Cardiovasc Med. 2020 Oct 30;7:580419. doi: 10.3389/fcvm.2020.580419. eCollection 2020.
4
Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry.血管扩张性β受体阻滞剂在急性心肌梗死患者中的长期疗效：全国多中心前瞻性注册研究。
Korean J Intern Med. 2021 Mar;36(Suppl 1):S62-S71. doi: 10.3904/kjim.2020.135. Epub 2020 Jul 3.
5
Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease.用于冠状动脉疾病诊断和管理的冠状动脉血管功能障碍的无创定量分析
J Nucl Cardiol. 2012 Oct;19(5):1060-72; quiz 1075. doi: 10.1007/s12350-012-9590-1.
6
Use of carvedilol in hypertension: an update.卡维地洛在高血压治疗中的应用：最新进展
Vasc Health Risk Manag. 2012;8:307-22. doi: 10.2147/VHRM.S31578. Epub 2012 May 18.
7
Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: a comparison with atenolol (CENTRAL Study).卡维地洛降低主动脉波反射，改善左心室/血管耦联：与阿替洛尔的比较（CENTRAL 研究）。
J Clin Hypertens (Greenwich). 2011 Dec;13(12):917-24. doi: 10.1111/j.1751-7176.2011.00549.x. Epub 2011 Nov 7.
8
Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension.比较比索洛尔和阿替洛尔对原发性高血压患者血压、血糖和血脂谱的影响。
Indian J Pharmacol. 2011 Jul;43(4):437-40. doi: 10.4103/0253-7613.83117.
9
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.比索洛尔：联合β阻断和一氧化氮释放的血液动力学效应及临床意义。
Drugs. 2010;70(1):41-56. doi: 10.2165/11530710-000000000-00000.
10
Beta-blockers and coronary flow reserve: the importance of a vasodilatory action.β受体阻滞剂与冠状动脉血流储备：血管舒张作用的重要性。
Drugs. 2008;68(5):579-90. doi: 10.2165/00003495-200868050-00002.

本文引用的文献

1
Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease.奈必洛尔可改善无冠心病的高血压患者的冠状动脉血流储备。
J Hypertens. 2004 Nov;22(11):2201-8. doi: 10.1097/00004872-200411000-00024.
2
Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.奈必洛尔可逆转原发性高血压患者的内皮功能障碍：一项随机、双盲、交叉研究。
Circulation. 2001 Jul 31;104(5):511-4. doi: 10.1161/hc3001.094207.
3
The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.奈必洛尔在原发性高血压患者前臂血管系统中的血管舒张作用。
Br J Clin Pharmacol. 1999 Sep;48(3):460-3. doi: 10.1046/j.1365-2125.1999.00037.x.
4
Noninvasive assessment of coronary flow reserve with transthoracic signal-enhanced Doppler echocardiography.经胸信号增强多普勒超声心动图对冠状动脉血流储备的无创评估。
J Am Soc Echocardiogr. 1999 Mar;12(3):186-95. doi: 10.1016/s0894-7317(99)70134-3.
5
Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia.冠状动脉阻力血管内皮依赖性血管舒张功能受损与运动诱发的心肌缺血有关。
Circulation. 1995 May 1;91(9):2345-52. doi: 10.1161/01.cir.91.9.2345.
6
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.
N Engl J Med. 1988 Nov 17;319(20):1302-7. doi: 10.1056/NEJM198811173192002.